EquiFund II is a Fund-of-Funds with portfolio of €200 million, which aims to support innovative enterprises active in two promising sectors of Greece’s economy: a) Life sciences & Healthcare and b) Sustainability & Social impact. The initiative will support these enterprises to enable better access to equity funding and increase their competitiveness by making full use of their development potential.
EquiFund II will support new and/or existing capital management groups will concurrently aiming to cover the funding gap in sectors with promising prospects for development and relatively few choices for funding by the state. The Fund will provide investments for enterprises at every stage (pre-seed, seed and early stage) as well as for development. Depending on market needs, the operation of the Fund is expected to benefit the entire investment spectrum and ecosystem of business capital and private holdings.
EquiFund II will invest in capital managed by Financial Intermediaries (FI) selected in accordance with the standard procedures of the European Investment Fund (EIF) through the relevant Invitation for Expression of Interest. EquiFund II does not invest directly in enterprises. Instead, it will make investments through the selected Financial Intermediaries (FI).
EquiFund II is a financial instrument and constitutes an Action of Strategic Importance under the Competitiveness Programme (NSRF 2021-2027), co-funded by the European Union.
The European Investment Fund will select the FIs through the relevant application submission and evaluation procedure. The deadline for submission of applications is 30 September 2024 (latest date of reception of electronic correspondence by the EIF).
Applications and requests for clarifications may be submitted exclusively via email to the EquiFund II group, at the address: equifundii@eif.org
See the announcement at the website of the European Investment Fund
To see the Press Release of the Ministry of National Economy and Finance
